FDA approves Sivextro to treat skin infections

Arirang News 2014-06-23

Views 9

Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA approves Sivextro to treat skin infections
play
00:40

FDA approves Sivextro to treat skin infections
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
02:17

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
00:49

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
play
01:34

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves Moderna's COVID-19 vaccine
play
00:39

U.S. FDA approves Moderna's COVID-19 vaccine
U.S. FDA approves genetically modified salmon for human consumption
play
01:34

U.S. FDA approves genetically modified salmon for human consumption
FDA approves first at-home COVID-19 test kit which doesn't require prescription
play
00:34

FDA approves first at-home COVID-19 test kit which doesn't require prescription
U.S. FDA approves first antigen test kit for COVID-19
play
00:49

U.S. FDA approves first antigen test kit for COVID-19
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
01:56

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
02:28

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
play
00:51

U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
play
02:12

FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.